Recce Ltd has released a press release.
Quarterly Activities/Appendix 4C Cash Flow Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Recce Pharmaceuticals Ltd. on 6ix
Earlier from Recce Pharmaceuticals
- AUD $5.3m R&D Rebate Received
- RCE Awarded Advanced Overseas Finding up to A$85m
- Hong Kong Patent Granted for RECCE Anti-Infectives
- Positive Efficacy Data for Inhaled R327 in HAP/VAP Model
- Patient Dosing Underway in Ph 3 Indonesia DFI Trial
Later from Recce Pharmaceuticals
- Recce Enters Second U.S. Department of Defense R&D Agreement
- Appendix 4D and Interim Financial Report
- RCE Investor Webinar Presentation Deck
- Brazil Patent Granted for RECCE Anti-Infectives
- Recce Signs Middle East Licensing Term Sheet
Follow Recce Pharmaceuticals into a list and get an email when it puts out news.
Follow Recce Pharmaceuticals